Good clinical response to alectinib, a second generation ALK inhibitor, in refractory neuroblastoma

Saved in:
Bibliographic Details
Published inPediatric blood & cancer Vol. 65; no. 7; pp. e27055 - n/a
Main Authors Heath, John A., Campbell, Marty A., Thomas, Alison, Solomon, Ben
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.07.2018
Subjects
Hematology
Neuroblastoma
Oncology
Pediatrics
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Correspondence-2
content type line 14
ObjectType-Letter to the Editor-1
ObjectType-Case Study-2
ObjectType-Correspondence-3
content type line 23
ObjectType-Report-1
ISSN:1545-5009
1545-5017
1545-5017
DOI:10.1002/pbc.27055